AU2003261424A8 - Nitrosated and/or nitrosylated ursodeoxycholic acid compounds, compositions and methods of use - Google Patents

Nitrosated and/or nitrosylated ursodeoxycholic acid compounds, compositions and methods of use

Info

Publication number
AU2003261424A8
AU2003261424A8 AU2003261424A AU2003261424A AU2003261424A8 AU 2003261424 A8 AU2003261424 A8 AU 2003261424A8 AU 2003261424 A AU2003261424 A AU 2003261424A AU 2003261424 A AU2003261424 A AU 2003261424A AU 2003261424 A8 AU2003261424 A8 AU 2003261424A8
Authority
AU
Australia
Prior art keywords
nitrosylated
nitrosated
compositions
methods
acid compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2003261424A
Other versions
AU2003261424A1 (en
Inventor
David S Garvey
Radha Iyengar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitromed Inc
Original Assignee
Nitromed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitromed Inc filed Critical Nitromed Inc
Publication of AU2003261424A8 publication Critical patent/AU2003261424A8/en
Publication of AU2003261424A1 publication Critical patent/AU2003261424A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003261424A 2002-08-06 2003-08-06 Nitrosated and/or nitrosylated ursodeoxycholic acid compounds, compositions and methods of use Abandoned AU2003261424A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40103602P 2002-08-06 2002-08-06
US60/401,036 2002-08-06
PCT/US2003/024689 WO2004012686A2 (en) 2002-08-06 2003-08-06 Nitrosated and/or nitrosylated ursodeoxycholic acid compounds, compositions and methods of use

Publications (2)

Publication Number Publication Date
AU2003261424A8 true AU2003261424A8 (en) 2004-02-23
AU2003261424A1 AU2003261424A1 (en) 2004-02-23

Family

ID=31495917

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003261424A Abandoned AU2003261424A1 (en) 2002-08-06 2003-08-06 Nitrosated and/or nitrosylated ursodeoxycholic acid compounds, compositions and methods of use

Country Status (2)

Country Link
AU (1) AU2003261424A1 (en)
WO (1) WO2004012686A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772220B2 (en) 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
US7851486B2 (en) 2002-10-17 2010-12-14 Decode Genetics Ehf. Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
US7507531B2 (en) 2002-10-17 2009-03-24 Decode Genetics Chf. Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction
BRPI0514725A (en) 2004-08-30 2008-06-24 Seo Hong Yoo neuroprotective effect of solubilized udca in the focal ischemic model
ATE506955T1 (en) 2004-10-15 2011-05-15 Seo Hong Yoo COMPOSITIONS FOR REDUCING THE TOXICITY OF CISPLATIN, CARBOPLATIN AND OXALIPLATIN
DE602005025391D1 (en) * 2004-11-01 2011-01-27 Seo Hong Yoo METHOD AND COMPOSITIONS FOR REDUCING NEURODE GENERATION IN AMYOTROPHIC LATERAL SCLEROSIS
GB0617581D0 (en) * 2006-09-07 2006-10-18 Ucl Business Plc Biomarkers for assessing liver function
CN102250185B (en) * 2010-05-19 2015-06-10 天津金耀集团有限公司 Glucocorticoid with NMDA ester positioned on site 21
CN102850426B (en) * 2011-07-01 2015-12-02 天津金耀集团有限公司 A kind of 21 is the glucocorticosteroid of N-acetylcystein ester
WO2017049044A1 (en) * 2015-09-16 2017-03-23 Bartolucci Giampiero Ursodeoxycholic acid and brain disorders
CN113166067A (en) * 2018-09-28 2021-07-23 加利福尼亚大学董事会 Compounds and methods for treating gastrointestinal disorders

Also Published As

Publication number Publication date
WO2004012686A2 (en) 2004-02-12
AU2003261424A1 (en) 2004-02-23
WO2004012686A3 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
EP1718286A4 (en) Nitrosated and/or nitrosylated compounds, compositions and methods of use
EP1667643A4 (en) Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
AU2003293529A8 (en) Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use
IL150368A0 (en) Nitrosated and nitrosylated cyclooxygenase-2-inhibitors, compositions and methods of use
EP1670459A4 (en) Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
AU7007001A (en) Nitrosated and nitrosylated taxanes, compositions and methods of use
AU2001270070A1 (en) Nitrosated and nitrosylated taxanes, compositions and methods of use
EP1539729A4 (en) Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
IL179445A0 (en) 1-methyl-3-trifluoromethyl-pyrazole-4-carboxylic acid (ortho-phenyl)-anilides and use thereof as fungicide
AU2003291668A8 (en) Sacrificial compositions, methods of use thereof, and methods of decomposition thereof
EP1539193A4 (en) Compositions of hyaluronic acid and methods of use
EP1534278A4 (en) Nitrosated proton pump inhibitors, compositions and methods of use
AU2003256805A8 (en) Compounds compositions and methods
EP1673384A4 (en) Nitrosated glutamic acid compounds, compositions and methods of use
HK1080359A1 (en) Cosmetic compositions with reduced tack
TWI293066B (en) Cement admixture
EP1633851A4 (en) Methods and compositions for amino acid production
AU2003261424A8 (en) Nitrosated and/or nitrosylated ursodeoxycholic acid compounds, compositions and methods of use
EP1539134A4 (en) Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
TW200613308A (en) Cyclobutanetetracarboxylate compound and preparation method thereof
TWI367753B (en) Composition for normalization of infradian rhythm
EP1154771A4 (en) Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use
TWI340160B (en) Organic acid containing compositions and methods for use thereof
EP1552826A4 (en) Amino acid compositions for improving central functions
DE60327253D1 (en) FOOD COMPOSITION CONTAINING L (+) - MILKY ACID

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase